Passa al contenuto
Merck
  • Heme oxygenase-1-mediated autophagy protects against pulmonary endothelial cell death and development of emphysema in cadmium-treated mice.

Heme oxygenase-1-mediated autophagy protects against pulmonary endothelial cell death and development of emphysema in cadmium-treated mice.

American journal of physiology. Lung cellular and molecular physiology (2015-06-14)
Ranu Surolia, Suman Karki, Hyunki Kim, Zhihong Yu, Tejaswini Kulkarni, Sergey B Mirov, A Brent Carter, Steven M Rowe, Sadis Matalon, Victor J Thannickal, Anupam Agarwal, Veena B Antony
ABSTRACT

Pulmonary exposure to cadmium, a major component of cigarette smoke, has a dramatic impact on lung function and the development of emphysema. Cigarette smoke exposure induces heme oxygenase-1 (HO-1), a cytoprotective enzyme. In this study, we employed a truncated mouse model of emphysema by intratracheal instillation of cadmium (CdCl2) solution (0.025% per 1 mg/kg body wt) in HO-1(+/+), HO-1(-/-), and overexpressing humanized HO-1 bacterial artificial chromosome (hHO-1BAC) mice. We evaluated the role of HO-1 in cadmium-induced emphysema in mice by analyzing histopathology, micro-computed tomography scans, and lung function tests. CdCl2-exposed HO-1(-/-) mice exhibited more severe emphysema compared with HO-1(+/+) or hHO-1BAC mice. Loss of pulmonary endothelial cells (PECs) from the alveolar capillary membrane is recognized to be a target in emphysema. PECs from HO-1(+/+), HO-1(-/-), and hHO-1BAC were employed to define the underlying molecular mechanism for the protection from emphysema by HO-1. Electron microscopy, expression of autophagic markers (microtubule-associated protein 1B-light chain 3 II, autophagy protein 5, and Beclin1) and apoptotic marker (cleaved caspase 3) suggested induction of autophagy and apoptosis in PECs after CdCl2 treatment. CdCl2-treated HO-1(-/-) PECs exhibited downregulation of autophagic markers and significantly increased cleaved caspase 3 expression and activity (∼4-fold higher). Moreover, hHO-1BAC PECs demonstrated upregulated autophagy and absence of cleaved caspase 3 expression or activity. Pretreatment of HO-1(+/+) PECs with rapamycin induced autophagy and resulted in reduced cell death upon cadmium treatment. Induction of autophagy following CdCl2 treatment was found to be protective from apoptotic cell death. HO-1 induced protective autophagy in PECs and mitigated cadmium-induced emphysema.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Sodio dodecil solfato, BioReagent, suitable for electrophoresis, Molecular Biology, ≥98.5% (GC)
Sigma-Aldrich
Sodio dodecil solfato, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
Sodio dodecil solfato, ACS reagent, ≥99.0%
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, Molecular Biology, 10% in H2O
Sigma-Aldrich
Sodio dodecil solfato, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, Molecular Biology, ≥99.0% (GC)
Sigma-Aldrich
Sodio dodecil solfato, BioUltra, 20% in H2O
Supelco
Sodio dodecil solfato, dust-free pellets, suitable for electrophoresis, Molecular Biology, ≥99.0% (GC)
Sigma-Aldrich
Cadmium chloride, 99.99% trace metals basis
Sigma-Aldrich
Sodio dodecil solfato, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
Sodio dodecil solfato, ≥98.0% (GC)
Sigma-Aldrich
Sodio dodecil solfato, 92.5-100.5% based on total alkyl sulfate content basis
Sigma-Aldrich
Acetyl-β-methylcholine chloride, ≥98% (TLC), powder
Sigma-Aldrich
Cadmium chloride
Sigma-Aldrich
Sodio dodecil solfato, ≥90% ((Assay))
Sigma-Aldrich
Sodio dodecil solfato, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
Sigma-Aldrich
Sodio dodecil solfato, BioReagent, suitable for electrophoresis, Molecular Biology, ≥98.5% (GC), free-flowing, Redi-Dri